EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the closing of its previously announced firm commitment underwritten public offering of 23,000,000 shares of the Company’s common stock, which includes 3,000,000 shares pursuant to the underwriters’ exercise of their option in full, at a purchase price to the public of $2.00 per share, resulting in net proceeds to the Company of $43.2 million (before estimated offering expenses payable by the Company). Piper Jaffray & Co. is acting as the sole book-running manager for the offering. Raymond James & Associates, Inc. and Oppenheimer & Co. Inc. are acting as the co-managers of the offering.
Help employers find you! Check out all the jobs and post your resume.
